Class III β-tubulin overexpression in ovarian clear cell and serous carcinoma as a maker for poor overall survival after platinum/taxane chemotherapy and sensitivity to patupilone.
about
miR-200c Regulation of Metastases in Ovarian Cancer: Potential Role in Epithelial and Mesenchymal TransitionOverexpression of Class III β-tubulin, Sox2, and nuclear Survivin is predictive of taxane resistance in patients with stage III ovarian epithelial cancer.Optimized Prediction of Extreme Treatment Outcomes in Ovarian Cancer.Improved i.p. drug delivery with bioadhesive nanoparticles.Class III β-tubulin overexpression within the tumor microenvironment is a prognostic biomarker for poor overall survival in ovarian cancer patients treated with neoadjuvant carboplatin/paclitaxelTargeted therapy in uterine serous carcinoma: an aggressive variant of endometrial cancer.Recent progress with microtubule stabilizers: new compounds, binding modes and cellular activities.Biomarkers predicting chemotherapy response in head and neck squamous cell carcinoma: a review.Molecular diagnosis and molecular profiling to detect treatment-resistant ovarian cancer.Polymerase ε (POLE) ultra-mutation in uterine tumors correlates with T lymphocyte infiltration and increased resistance to platinum-based chemotherapy in vitro.Preoperative Anti-Class III β-Tubulin Antibodies As Relevant Clinical Biomarkers in Ovarian Cancer.In vitro and in vivo activity of IMGN853, an Antibody-Drug Conjugate targeting Folate Receptor Alpha linked to DM4, in biologically aggressive endometrial cancers.
P2860
Q28071987-E3F350EB-93CD-4D50-9F56-B05A693BD066Q35703969-7DDB49C8-BB52-4867-8D4C-37504130C4AFQ36726141-E90B6695-9AFE-48FD-BB0D-866EC952250BQ37346875-DF12327F-4B01-465B-BDDF-A528A732837AQ37625835-94EFF7E9-FED8-4E1F-BF63-B389F980D4E1Q37699264-FA446DD2-CAF2-4820-BBBF-5E6AD981411CQ38183686-CE8B3145-62BE-4501-85CE-5F3196F99AA0Q38597457-55F02036-9867-48A1-9EDC-3135365999BCQ38832323-BCAAFA2F-32DF-41AF-8733-2B907341323AQ47104826-F770B5E5-DE19-462A-8A94-74EAF1089E31Q49967636-1187DBBE-26E0-4FFB-97F0-A5A9AA994614Q50027073-7BDEB03E-5AD3-4993-ADFA-247F5C5347B0
P2860
Class III β-tubulin overexpression in ovarian clear cell and serous carcinoma as a maker for poor overall survival after platinum/taxane chemotherapy and sensitivity to patupilone.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Class III β-tubulin overexpres ...... and sensitivity to patupilone.
@en
Class III β-tubulin overexpres ...... and sensitivity to patupilone.
@nl
type
label
Class III β-tubulin overexpres ...... and sensitivity to patupilone.
@en
Class III β-tubulin overexpres ...... and sensitivity to patupilone.
@nl
prefLabel
Class III β-tubulin overexpres ...... and sensitivity to patupilone.
@en
Class III β-tubulin overexpres ...... and sensitivity to patupilone.
@nl
P2093
P1476
Class III β-tubulin overexpres ...... and sensitivity to patupilone.
@en
P2093
Alessandro D Santin
Dana M Roque
Eliana Bignotti
Emiliano Cocco
Natalia Buza
Peter E Schwartz
Sergio Pecorelli
Stefania Bellone
Thomas J Rutherford
P304
P356
10.1016/J.AJOG.2013.04.017
P407
P577
2013-04-10T00:00:00Z